Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
European Regulators Call for Drug Companies to Release Clinical Trial Data October 28, 2013 Irvin Jackson Add Your CommentsA recent editorial written by experts from the European Medicines Agency (EMA) calls for drug companies to publicly release all patient-level clinical trial data, which they indicate would help protect public health and diminish distrust in industry-sponsored studies. ย The perspective piece was published in the New England Journal of Medicine on October 21. The experts from the EMA who wrote the editorial recently published a draft policy (PDF)ย that would require patient-level data submitted to the EMA by drug companies and other researchers be made accessible to the public. The FDA has made similar proposals.According to the editorial, drug companies are worried that the patient-level trial data, more specific than what is usually released when clinical trials are published, would allow competitors to access company trade secrets and proprietary information. However, the EMA argues that full transparency, with patient identities protected, would benefit drug developers.Stay Up-to-Date AboutMedtronic Infuse Bone Graft LawsuitsAboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Medtronic lawsuit updates or developments. "*" indicates required fieldsEmail* SIGN ME UPΔ Learn MoreStay Up-to-Date AboutMedtronic Infuse Bone Graft LawsuitsAboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Medtronic lawsuit updates or developments."*" indicates required fieldsEmail* SIGN ME UPΔ Learn More“Contrary to industry fears, we argue that access to full — though appropriately deidentified — data sets from clinical trials will benefit the research-based biopharmaceutical industry,” they wrote. “We predict that it will help to increase the efficiency of drug development, improve cost-effectiveness, improve comparative-effectiveness analysis, and reduce duplication of effort among trial sponsors.”Drug industry lobbyists also wrote an editorial in the NEJM, indicating that new rules and disclosures need to be handled with caution.“A leading concern in expanding access to participant-level data is whether the privacy of research participants can be guaranteed,” wrote representatives of the Pharmaceutical Research and Manufacturers of America. “It is difficult to effectively deidentify certain data — especially data from trials concerning rare diseases or other small trials — without rendering them useless.”The integrity of industry clinical trial data has come under fire in recent years in the wake of a number of incidents regarding claims of ghost-writing and deliberate hiding or downplaying of drug risks and side effects.Last year, aย congressional investigationย determined that Medtronic paid $210 million to study authors that failed to include data on complications linked to its Infuse bone growth product in their reports. Those authors not only failed to disclose links to Medtronic, but the investigation also determined that Medtronic employees secretly edited and sometimes wrote parts of the studies before they were published, which encouraged the off-label use of Infuse.A growing number ofย Medtronic Infuse lawsuits are now being pursuedย in state and federal courts throughout the country by individuals who allege that the off-label use of the device resulted in excessive bone growth around the spine, causing plaintiffs to suffer nerve compression, paralysis, airway compression, retrograde ejaculations, urinary retention, cancer and other serious health problems. Plaintiffs have maintained that they suffered Infuse-related complications because Medtronic illegally promoted Infuse for uses not approved by FDA without fully informing doctors and patients of the risks. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Congress, Drug Side Effects, Infuse, MedtronicMore Medtronic Infuse Lawsuit Stories Medtronic Infuse Problems Hidden From Regulators, Report Claims April 12, 2016 Medtronic Infuse Lawsuit Appealed to U.S. Supreme Court Over Off-Label Marketing September 21, 2015 Side Effects of Bone Graft Substitutes Linked to Child Health Risks, FDA Warns January 22, 2015 0 CommentsPhoneThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Lawsuit Claims Abbott Sales Reps Practiced Medicine Without a License While Adjusting Spinal Cord Stimulator (Posted: 2 days ago)An Abbott SCS lawsuit claims the company’s sales representatives performed unlicensed medical procedures, potentially delaying removal of a failed implant.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITConsolidated Lawsuit Over Boston Scientific Spinal Cord Stimulator Problems Filed in MDL (11/09/2026)Abbott Sales Reps Kept Trying to Reprogram Failed SCS Implant: Lawsuit (11/02/2026)Abbott Proclaim Elite Lawsuit Alleges Spinal Cord Stimulator Malfunction Worsened Chronic Pain (10/29/2026) Parkinsonโs Disease Lawsuit Claims Dow and Corteva Sold Dangerous Chlorpyrifos Despite Safer Alternatives (Posted: 3 days ago)A California man’s chlorpyrifos lawsuit blames years of exposure to the pesticide for the development of Parkinson’s disease that forced him out of his profession.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITPesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (11/13/2026)Chlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026) Gabapentin Lawsuit Alleges Nerve Pain Drug Caused Severe Headaches, Memory Loss (Posted: 4 days ago)A Washington womanโs lawsuit claims she suffered persistent neurological problems after using gabapentin for fibromyalgia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITNeurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (11/10/2026)Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026)
Lawsuit Claims Abbott Sales Reps Practiced Medicine Without a License While Adjusting Spinal Cord Stimulator (Posted: 2 days ago)An Abbott SCS lawsuit claims the company’s sales representatives performed unlicensed medical procedures, potentially delaying removal of a failed implant.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITConsolidated Lawsuit Over Boston Scientific Spinal Cord Stimulator Problems Filed in MDL (11/09/2026)Abbott Sales Reps Kept Trying to Reprogram Failed SCS Implant: Lawsuit (11/02/2026)Abbott Proclaim Elite Lawsuit Alleges Spinal Cord Stimulator Malfunction Worsened Chronic Pain (10/29/2026)
Parkinsonโs Disease Lawsuit Claims Dow and Corteva Sold Dangerous Chlorpyrifos Despite Safer Alternatives (Posted: 3 days ago)A California man’s chlorpyrifos lawsuit blames years of exposure to the pesticide for the development of Parkinson’s disease that forced him out of his profession.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITPesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (11/13/2026)Chlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)
Gabapentin Lawsuit Alleges Nerve Pain Drug Caused Severe Headaches, Memory Loss (Posted: 4 days ago)A Washington womanโs lawsuit claims she suffered persistent neurological problems after using gabapentin for fibromyalgia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITNeurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (11/10/2026)Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026)